Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy
Condition: Obstructive Sleep Apnea Interventions: Drug: Atomoxetine; Drug: Oxybutynin Sponsor: Brigham and Women's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hospitals | Oxybutynin | Research | Sleep Apnea | Sleep Disorders | Sleep Medicine | Strattera | Women